News

Clinical Trials Arena7h
Scancell taps melanoma mAb for progression following positive Phase II results
Combining Scancell's melanoma drug iSCIB1+ with Yervoy and Opdivo significantly improved patient overall response rate.
Clinical Trials Arena12h
Diakonos initiates dosing in Phase II trial of glioblastoma treatment
Diakonos Oncology has dosed the first subject in its Phase II trial of DOC1021 for treating glioblastoma (GBM).
Clinical Trials Arena13h
Arch Biopartners’ Phase II AKI prevention trial begins patient recruitment
Arch Biopartners has initiated subject recruitment in its Phase II study aimed at assessing cilastatin in preventing AKI.